Skip to main content
. 2022 Mar 2;109(4):571–586. doi: 10.1016/j.ajhg.2022.01.020

Table 1.

Clinical features of affected individuals with TIAM1 variants

Proband 1 MZ twin of proband 1 Proband 2 Proband 3 Proband 4
TIAM1 variant (GenBank: NM_001353694.2) c.67C>T (p.Arg23Cys); c.2584C>T (p.Leu862Phe) c.67C>T (p.Arg23Cys); c.2584C>T (p.Leu862Phe) c.983G>T (p.Gly328Val) c.4640C>A (p.Ala1547Glu) c.1144G>C (p.Gly382Arg); c.4016C>T (p.Ala1339Val)
Genomic DNA, GRCh38 21:31266906 G>A; 21:31187079 G>A 21:31266906 G>A; 21:31187079 G>A 21:31252170 C>A 21:31120504 G>T 21:31252009 C>G; 21:31130242 G>A
CADD score 29.1; 23.7 29.1; 23.7 25.4 18.1 23.9; 26.7
Allele frequency (gnomAD) 4.04e−4; 3.98e−6 4.04e−4; 3.98e−6 8.18e−6 0 5.66e−5; 3.98e−6
Zygosity compound heterozygous compound heterozygous homozygous homozygous compound heterozygous
Sex M M M M F
Current age 35 years 35 years 3 years 7 years 6 years
Developmental delay + + + + +
Intellectual disability + + N/A + (severe) + (severe)
Delayed speech + + + + (non-verbal) + (severe)
Autism + + N/A N/A N/A
ADD/ADHD + + N/A N/A N/A
Seizures + + +, complex febrile seizures (abnormal EEGs) + + (severe)
Brain MRI N/A N/A progressive macrocephaly (secondary to chronic subdural hematoma and extra-axial fluid) diffuse cerebral atrophy; thin corpus callosum; hypomyelination; deep cortical sulcus hypothalamic hamartoma
Other neurological symptoms none impulsive, obsessive behavior axial hypotonia; appendicular hypertonia none N/A
Endocrine symptoms hypothyroidism; Addison’s disease hypothyroidism subclinical hypothyroidism hypomagnesemia N/A
Other none none dysmorphic features; congenital heart defect (atrial and ventricular septal defects); undescended testes poor growth (difficulty in gaining weight); undescended testis; hirsutism none
Consanguinity none none + + none

MZ, monozygotic; CADD, combined annotation dependent depletion; M, male; N/A, not available; ADD, attention deficit disorder; ADHD, attention deficit hyperactivity disorder; EEG, electroencephalography.